Sudershan Biotech is located in Hyderabad, India, by far the leader in generic, emerging and green-field Pharmaceutical and Biotech activities. Sudershan Biotech Limited, founded in March 1999 is actively involved in developing Recombinant products for Human use. The major focus areas of Sudershan Biotech Limited include therapeutic proteins, diagnostic proteins and industrial enzymes.

It has a well experienced team of bio-scientists who work under the supervision and guidance of Dr.Ramareddy V. Guntaka, in a state-of-art faculty at L.B Nagar, Hyderabad. Dr.R.V. Guntaka is a professor in Department of Molecular Sciences, College of Medicine, University of Tennessee Health Science Centre, Memphis. He was conferred the Genome Valley Excellence Award for his outstanding contribution to the field of Biotechnology in February 2006.

The Andhra Pradesh Government has been using the BioAsia events as a platform to recognise and acknowledge the outstanding efforts of distinguished scientists in the life sciences sector by honouring them with 'Genome Valley Excellence Awards'. This year, Prof Rama Reddy V Guntaka, Department of Molecular Sciences, College of Medicine, University of Tennessee Health Science Centre, Memphis will be conferred the award for his contribution to the field of biotechnology.

Guntaka's research with fellow scientists D Stehelin, HE Varmus and JM Bishop resulted in the discovery of protooncogenes for which Bishop and Varmus won Nobel Prize in 1989.

He worked in the laboratories of two Hyderabad-based biotech companies-Shantha Biotechnics and Sudershan Biotech. He succeeded in cloning the whole molecule and sequenced the genome of the hepatitis C virus, mapping its 9,500 nuceotides. He is the first to molecularly clone the entire genome of Rous Sarcoma Virus which is being used all over the world as a prototype virus for understanding cancer.

Guntaka was also behind the successful development of Shantha Biotech's recombinant hepatitis B vaccine (Shanvac) and the hepatitis C vaccine (Shanferon). He is guiding scientists at Sudershan Biotech to produce antigens to detect the hepatitis C virus, hepatitis B virus and human immunodeficienct virus (HIV) infections.

The third edition of Bio Asia, which was held at Hyderabad from February 9-11, 2006 attracted over 500 delegates, 58 sponsors and exhibitors from 33 countries. The summit has bridged the Asian and global biotech communities.

Dr Anward Nasim, president of Federation of Asian Biotech Associations (FABA) commenting on the growing co-operation among Asian biotech countries, said, "Bio Asia 2006 has played a significant role in creating a platform for Asian biotech companies to interact and collaborate. The formation of FABA has brought India and Pakistan close in the area of biotechnology."

Eminent scientists and business leaders from diverse backgrounds presented and exchanged views on issues such as bio-entrepreneurship, clinical trials, investment opportunities in biotechnology and venture funding, leveraging logistics to enhance supply chain management in pharmaceuticals, bio-cluster development in India.

Prof Guntaka Rama Reddy, Department of Molecular Sciences, College of Medicine, University of Tennessee Health Science Centre, Memphis was conferred the Genome Valley Excellence Award for his outstanding contribution to the field of biotechnology.

Lakshmi Parthasarathy, prinicipal secretary, Ministry of Industries, Government of AP, announced that the fourth edition of Bio Asia will be held from February 15-17, 2007.